Pfizer submits COVID-19 vaccine trial data to Health Canada for kids under 12
Pfizer has submitted to Health Canada its preliminary data on the effectiveness of its COVID-19 vaccine in children ages five to 11, the department confirmed Saturday.
Pfizer has submitted to Health Canada its preliminary data on the effectiveness of its COVID-19 vaccine in children ages five to 11, the department confirmed Saturday.
/